1328995-70-5

Basic information

• Product Name: 4-[[2-[[2-(4-cyclopropylsulfonylphenyl)-2-(2,4-difluorophenoxy)acetyl]amino]thiazol-5-yl]methyl]benzoic acid
• CAS NO: 1328995-70-5
• Molecular Weight: 584.621
• Mol File: 1328995-70-5.mol

Chemical Properties

• CAS DataBase Reference: 4-[[2-[[2-(4-cyclopropylsulfonylphenyl)-2-(2,4-difluorophenoxy)acetyl]amino]thiazol-5-yl]methyl]benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[[2-[[2-(4-cyclopropylsulfonylphenyl)-2-(2,4-difluorophenoxy)acetyl]amino]thiazol-5-yl]methyl]benzoic acid(1328995-70-5)
• EPA Substance Registry System: 4-[[2-[[2-(4-cyclopropylsulfonylphenyl)-2-(2,4-difluorophenoxy)acetyl]amino]thiazol-5-yl]methyl]benzoic acid(1328995-70-5)

Safety Data

• Hazardous Substances Data: 1328995-70-5(Hazardous Substances Data)

Upstream product

• 108-98-5 thiophenol 
• 745052-94-2 ethyl 2-(4-cyclopropylsulfanylphenyl)-2-oxoacetate 
• 14633-54-6 cyclopropylphenylsulfide 
• 868614-26-0 2-(4-cyclopropylsulfanylphenyl)-2-oxoacetic acid 
• 1143510-49-9 2-(4-cyclopropanesulfonylphenyl)-2-(2,4-difluorophenoxy)acetic acid 
• 1080059-87-5 methyl 2-(4-cyclopropylsulfonylphenyl)acetate 
• 868614-27-1 2-(4-cyclopropylsulfanylphenyl)acetic acid 

Relevant articles and documents

Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia

Glucokinase activators (GKAs) are among the emerging drug candidates for the treatment of type 2 diabetes (T2D). Despite effective blood glucose lowering in clinical trials, many pan-GKAs “acting both in pancreas and liver” have been discontinued from cli

ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND MEDICINAL APPLICATION

Acetamide derivatives, their stereoisomers, tautomers, prodrugs, pharmaceutically acceptable salts, polymorphs, solvates and formulations thereof for the prophylaxis, management, treatment, control of progression, or adjunct treatment of diseases and/or m